TRANSARTERIAL RADIOEMBOLIZATION USING YTTRIUM-90 MICROSPHERES IS A THERAPEUTIC OPTION FOR PATIENTS WITH INTERMEDIATE-OR ADVANCED-STAGE HEPATOCELLULAR CARCINOMA, INCLUDING THOSE WITH RECURRENT OR INOPERABLE HEPATOCELLULAR CARCINOMA.

PURCHASE ORDER won by BOSTON SCIENTIFIC CORP · work in JBSA FT SAM HOUSTON, TX
$552,770
RecipientBOSTON SCIENTIFIC CORP UEI YWDHHW3DLNQ1
Award IDW81K0025PA252
Award amount$552,770
Award typePURCHASE ORDER
Awarding agencyDepartment of Defense — Department of the Army
NAICS325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
PSC6515
Set-asideUnrestricted
Start dateOct 1, 2025
End dateSep 30, 2026
Place of performanceJBSA FT SAM HOUSTON, TX
Record updatedDec 30, 2025

View the official award record

More awards won by BOSTON SCIENTIFIC CORP

THERASPHERE Y-90 GLASS MICROSPHERE MEDICATION
Department of Veterans Affairs · $3,800,340 · Oct 1, 2022
EXPRESS REPORT: BOSTON SCIENTIFIC CONSIGNMENT AGREEMENT EXPENDITURES.
Department of Veterans Affairs · $1,673,771 · Jan 1, 2022
CARDIAC HOLSTER MONITORING SERVICES
Department of Veterans Affairs · $1,631,354 · Sep 30, 2023
Y90 THERESPHERE
Department of Veterans Affairs · $1,526,225 · Jan 1, 2024
YTTRIUM-90 THERASPHERES
Department of Veterans Affairs · $1,080,000 · Apr 1, 2021

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids